2007
DOI: 10.1016/j.transproceed.2007.02.063
|View full text |Cite
|
Sign up to set email alerts
|

Low-Dose Hormonal Contraception After Liver Transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
29
1
1

Year Published

2008
2008
2021
2021

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 60 publications
(34 citation statements)
references
References 7 publications
0
29
1
1
Order By: Relevance
“…Variations in CK and AST activities were reported to be associated with liver and heart disease (30,31). However, the present study revealed that activity levels of the two enzymes differed between the in vivo and in vitro experiments; in addition, activity levels of AST and CK in the supernatants of heat-stressed H9c2 cells as well as the sera of the heat-stressed rats exhibited significant variations.…”
Section: Discussioncontrasting
confidence: 69%
“…Variations in CK and AST activities were reported to be associated with liver and heart disease (30,31). However, the present study revealed that activity levels of the two enzymes differed between the in vivo and in vitro experiments; in addition, activity levels of AST and CK in the supernatants of heat-stressed H9c2 cells as well as the sera of the heat-stressed rats exhibited significant variations.…”
Section: Discussioncontrasting
confidence: 69%
“…Therefore, the integrity of cellular structure may be altered during the course of transportation (Witek et al, 1996). The presence of ALT and AST enzyme activities in blood serum are often associated with liver and heart disease (Jabiry-Zieniewicz et al, 2007;Radosavljević et al, 2008). Therefore, these enzymes can be monitored to evaluate stress in pigs during transportation.…”
Section: Discussionmentioning
confidence: 99%
“…Patients who have established normal organ function and are stable at least 6 to 8 months after transplantation can use any of the currently available hormonal contraceptives, provided they do not have other contraindications to the estrogen component. 58,254,257,[258][259][260] Contraindications to estrogen, however, occur more commonly in transplant recipients. For example, COCs should not be prescribed to patients with active liver dysfunction or coronary artery disease.…”
Section: Adolescent Recipients Of Solid Organ Transplantationmentioning
confidence: 99%